![Ribbon symbolism / Triple-negative breast cancer / PARP inhibitor / Sanofi / Targeted therapy / TNBC / Cancer / Breast cancer treatment / Medicine / Breast cancer / Oncology Ribbon symbolism / Triple-negative breast cancer / PARP inhibitor / Sanofi / Targeted therapy / TNBC / Cancer / Breast cancer treatment / Medicine / Breast cancer / Oncology](https://www.pdfsearch.io/img/680197765d14f26e644e5e53bba2189d.jpg) Date: 2009-05-13 16:49:54Ribbon symbolism Triple-negative breast cancer PARP inhibitor Sanofi Targeted therapy TNBC Cancer Breast cancer treatment Medicine Breast cancer Oncology | | Sanofi-aventis To Acquire BiPar Sciences First-in-class oncology medicine will provide new treatment option while adding to the company’s late stage development portfolio BRISBANE, California and PARIS, France – ApriAdd to Reading ListSource URL: capital.vulcan.comDownload Document from Source Website File Size: 104,19 KBShare Document on Facebook
|